Abstract
The WATCHMAN device is indicated for thromboembolic stroke prevention in patients with non-valvular atrial fibrillation who are at moderate to high stroke risk and have a contraindication for oral anticoagulation. It is unclear whether the implantation of the WATCHMAN left atrial appendage closure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have